Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
Schizophrenia (Heidelberg, Germany)|April 28, 2025
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative studySebastien Tulliez, Stella Karantzoulis, James C Marcus, et al.
Schizophrenia Research|April 24, 2017
Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patientsAnastasia Georgiades, Vicki G Davis, Alexandra S Atkins, et al.
Schizophrenia Research|September 9, 2008
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment StudyKeith A Hawkins, Richard S E Keefe, Bruce K Christensen, et al.
The American Journal of Psychiatry|September 14, 2013
Microvascular abnormality in schizophrenia as shown by retinal imagingMadeline H Meier, Idan Shalev, Terrie E Moffitt, et al.
Schizophrenia Research. Cognition|May 19, 2025
Assessment of the German Version of Brief Assessment of Cognition in Schizophrenia (BACS)Matin Mortazavi, Jakob Amon, Iris Jäger, et al.
Schizophrenia Research|August 30, 2005
The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndromeJonathan M Meyer, Henry A Nasrallah, Joseph P McEvoy, et al.
Journal of Psychiatric Research|December 11, 2020
Can IQ moderate the response to cognitive remediation in people with schizophrenia?Benedetta Seccomandi, Deborah Agbedjro, Morris Bell, et al.
Schizophrenia Research|November 18, 2008
Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of functionLeah Kleinman, Jeffrey Lieberman, Sanjay Dube, et al.
Schizophrenia Bulletin|May 13, 2005
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophreniaRobert W Buchanan, Miriam Davis, Donald Goff, et al.
The American Journal of Psychiatry|June 18, 2013
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) studyS Kristian Hill, James L Reilly, Richard S E Keefe, et al.
Pageof 24